Preimplantation Genetic Testing Market Growth and Forecast, 2014 - 2024.

The market is subject to witness a substantial growth due to the rising awareness in regards to genetic techniques and increasing adoption for detection of chromosomal abnormalities. Use of preimplantation genetic testing (PGD/PGS) for embryo screening to perform in vitro fertilization (IVF) is expected to boost market growth over the forecast period. Identification of genetic disorders and inherited conditions with the help of preimplantation genetic testing (PGT) and diagnosis is predicted to foster market growth over the upcoming years.

Globally, the preimplantation genetic testing industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the preimplantation genetic testing market. Early diagnosis of the chromosomal disorders helps to reduce the number of people suffering from congenital diseases. These factors are anticipated to fuel demand for preimplantation genetic testing (PGT) solutions. Increasing number of incidences of various gene-related disorders is estimated to favor market growth over the next seven years.

Download Free Sample  - https://www.millioninsights.com/industry-reports/preimplantation-genetic-testing-market/request-sample

Genetic testing identifies differences among genes that are related with disease or other behaviors. The genetic tests determine person susceptibility towards genetic disease. The testing also helps to understand the likelihood of a person to carry forward genetic mutation to their offspring. Preimplantation genetic testing is performed on various blood sample taken during different period in person’s life, for example, before the birth and until death of the individual. The fast paced technological advancement in genetic testing and sequencing methodologies, has led to the vast expansion of genetic testing in numerous health care sections to determine individual’s susceptibility towards complex disorders.

Pre-implantation genetic diagnosis (PGD or PIGD) is also referred as the genetic profiling of embryos prior to implantation. Pre-implantation genetic diagnosis (PGD or PIGD) is also used for profiling of oocytes prior to fertilization. Pre-implantation genetic diagnosis is carried out in similar way as that of prenatal diagnosis. Pre-implantation genetic diagnosis offer benefits such as selective pregnancy termination thus ensuring the baby will be free of the disease under consideration. Pre-implantation genetic diagnosis uses in vitro fertilization (IVF) to achieve oocytes or embryos for evaluation.

The preimplantation genetic testing (PGT) industry is broadly categorized into four major segments based on the application type such as embryo HLA typing for stem cell therapy, IVF prognosis, late-onset genetic disorders, and inherited genetic disease. The embryo HLA typing for stem cell therapy is considered as one of the fastest growing segment in the preimplantation genetic testing (PGT) market with substantial revenue generation in the last few years. Growing popularity of preimplantation genetic testing in the embryo HLA typing for stem cell therapy segment is attributed to increasing implementation of the hematopoietic stem cell transplantations via matched donors and significant improvements in overall survival rate.